Severe CMV complication following maintenance therapy with rituximab

BMJ Case Reports

Volumn , Issue , 2013, Pages

  Le Clech, Lenaïg ^a   Ianotto, Jean Christophe ^a   Quintin Roue, Isabelle ^a   Tempescul, Adrian ^a  

^a BREST UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD23 ANTIGEN; CD5 ANTIGEN; CHLORAMBUCIL; CIDOFOVIR; CYCLOPHOSPHAMIDE; DEXAMETHASONE; FLUDARABINE; IMMUNOGLOBULIN LAMBDA CHAIN; MITOXANTRONE; PREDNISONE; RITUXIMAB; VALGANCICLOVIR;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; DRUG SAFETY; GASTRITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN DEFICIENCY; IMMUNOPHENOTYPING; LYMPHOCYTOPENIA; MAINTENANCE THERAPY; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SPLENOMEGALY; STEREOTACTIC BIOPSY; TREATMENT DURATION; VIRUS ENCEPHALITIS; VIRUS REACTIVATION;

EID: 84872726191     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2012-006672     Document Type: Article

References (9)

1. Keating MJ, O'Brien S, Albitar M, et al. Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia. J Clin Oncol 2005;23:4079-88. (Pubitemid 46211313)
2. Gea-Banacloche JC. Rituximab-associated infections. Semin Hematol 2010;47:187-98.
3. Kelesidis T, Daikos G, Boumpas D, et al. Does rituximab increase the incidence of infectious complications? A narrative review. Int J Infect Dis 2011;15:e2-16.
4. Aksoy S, Harputluoglu H, Kilickap S, et al. Rituximab-related viral infections in lymphoma patients. Leuk Lymphoma 2007;48:1307-12. (Pubitemid 47079357)
5. Berthelot J-M, Jamin C, Amrouche K, et al. Regulatory B cells play a key role in immune system balance. Joint Bone Spine (Internet) 2012 juill 31 (cité 2012 sept 3); http://www.ncbi.nlm.nih.gov/pubmed/22858147
6. Hubacek P, Keslova P, Formankova R, et al. Cytomegalovirus encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet. Pediatr Transplant 2009;13:919-22.
7. Miller GG, Boivin G, Dummer JS, et al. Cytomegalovirus ventriculoencephalitis in a peripheral blood stem cell transplant recipient. Clin Infect Dis 2006;42:e26-9.
8. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002;34:1094-7. (Pubitemid 34289682)
9. Suzan F, Ammor M, Ribrag V. Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder. N Engl J Med 2001;345:1000.